Novocure to Present at JMP Securities 2016 Life Sciences Conference

Science

Presswire

Novocure to Present at JMP Securities 2016 Life Sciences Conference

[PRESSWIRE] ST. HELIER, Jersey – 08 June, 2016 — Novocure (NASDAQ: NVCR) today announced that Mike Ambrogi, Novocure’s Chief Operating Officer, will present at the JMP Securities 2016 Life Sciences Conference in New York. Mr. Ambrogi will present on Wednesday, June 22nd at 11:30 a.m. EDT.

A live audio webcast of the presentation will be available on Novocure’s website. The audio replay and presentation materials will be available via our website for at least 14 days following the presentation.

About Novocure

Novocure is a commercial-stage oncology company developing a novel, proprietary therapy called Tumor Treating Fields, or TTFields, for the treatment of solid tumor cancers. Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania, and New York City. Additionally, the company has offices in Germany, Switzerland and Japan, and a research center in Haifa, Israel. For additional information about the company, please visit www.novocure.com or follow us at www.twitter.com/novocure.

Contacts

Media and Investor Contact:
Novocure
Ashley Cordova, 212-767-7558
[email protected]